Squarepoint’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
Other funds holding CCXI
UOC
PCM
BBA
SFM
Squarepoint's CCXI Position: Q3 2022 in Review
Squarepoint sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 14,287 shares — an estimated $354K sold.
Squarepoint first reported a position in CCXI in Q3 2017 and held it in 16 quarters. The position peaked at $3.42M in Q3 2020. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.
- Squarepoint reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
- Squarepoint sold 14,287 ChemoCentryx, Inc. shares in Q3 2022, an estimated $354K.
- Squarepoint first reported a position in ChemoCentryx, Inc. in Q3 2017 and held it in 16 quarters.
- Squarepoint's ChemoCentryx, Inc. position peaked at $3.42M in Q3 2020.
- 217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.
Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.